Initiator Pharma A/S

Initiator Pharma A/S EBIT per Share

The EBIT per Share of Initiator Pharma A/S (INIT.ST) as of Nov 3, 2026 is -0.27 DKK. In the previous year, EBIT per Share was 0.01 DKK — a change of -4,769.40% (lower).

EBIT per Share

-0.27DKK

YoY

-4,769.40%

Last updated:

EBIT per Share of Initiator Pharma A/S is 2025 -0.27 DKK. EBIT per Share of Initiator Pharma A/S was 2024 0.01 DKK. It decreases by -4,769.40% lower compared to the previous year.

The Initiator Pharma A/S EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
0.02 DKK
Jan 1, 2022
-0.66 DKK
Jan 1, 2023
0.04 DKK
Jan 1, 2024
0.01 DKK
Jan 1, 2025
-0.27 DKK
Jan 1, 2026 (e)
-0.55 DKK
Jan 1, 2027 (e)
-0.31 DKK
Jan 1, 2028 (e)
-0.41 DKK
The Initiator Pharma A/S EBIT per Share history
YEAREBIT per ShareYoY
est-0.41DKK+33.33%
est-0.31DKK-44.07%
est-0.55DKK+107.61%
-0.27DKK-4,769.40%
0.01DKK-86.51%
0.04DKK-106.43%
-0.66DKK-3,911.42%
0.02DKK-6,919.18%
-0.00DKK+8.14%
-0.00DKK-47.41%
-0.00DKK-20.88%
-0.00DKK+618.60%
-0.00DKK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Initiator Pharma A/S Stock analysis

What does Initiator Pharma A/S do? Initiator Pharma A/S is a clinical-stage biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. The company develops novel therapeutics targeting monoamine reuptake transporters for central nervous system disorders, with a focus on erectile dysfunction treatments. Initiator Pharma A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Initiator Pharma A/S stock

EBIT per Share of Initiator Pharma A/S is -0.27 DKK in 2025.

EBIT per Share of Initiator Pharma A/S changed from 0.01 DKK to -0.27 DKK, representing a -4,769.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Initiator Pharma A/S since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Initiator Pharma A/S

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Initiator Pharma A/S